Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
ITRMF has basic price and filing data (45% intelligence coverage), but earnings analysis, financial metrics, and proprietary signals are still building. Explore a peer with deeper coverage below.
Intelligence coverage: 45%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 50% · prior close shown (market closed)
Limited proprietary earnings coverage for ITRMF yet — signals will sharpen as filings and earnings are ingested.
Pipeline evidence · 34d ago
Updated
What happened recently for Iterum Therapeutics plc (ITRMF) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
Prior close
—
Market cap
—
Profitable
No
Net income
$-24.77M
FY Dec 31, 2024
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for Iterum Therapeutics plc — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected companies and research pages from the AlphaOS knowledge graph.
Follow Iterum Therapeutics plc through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.